Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Preventing Atopic Dermatitis in High-Risk Children Using Paraffin White Soft Cream
GermanyStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis
BulgariaStudy on the Effect of Ciclopirox in Treating Nail Fungal Infection in Patients
SpainStudy on the Effectiveness of Nintedanib for Treating Nosebleeds in Patients with Hereditary Hemorrhagic Telangiectasia
FranceStudy on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment
FranceStudy on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
FranceStudy on the Effect and Safety of BW-20805 for Adults with Hereditary Angioedema
GermanyLong-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran
FranceStudy of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving encorafenib and binimetinib combination therapy
GermanyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
